discussed aspects such as how to assess renal recovery after AKI, and why it progresses to chronic kidney disease (CKD). The notion that ischemic, toxic or septic insults to the kidney will for the most part resolve without permanent damage is obsolete. AKI and CKD are linked in a bidirectional pathogenetic association, this is an important concept which has to be understood by those who are involved in patient care.
Management issues in day-to-day practice have also been dealt with. In critically ill patients fluid administration is a big challenge. Measurement of fluid responsiveness is difficult as less fluid may result in decreased cardiac output and more fluid may lead to sequestration in extravascular space. Timing of fluid administration and type of fluid to be given is well discussed in the chapter on fluid management in AKI. This will be of great use not only to doctors but also nursing staff who are an integral part of the team.
In the absence of any effective therapies to restore kidney function, AKI is usually managed by acute renal replacement therapy (ARRT), optimization of which may reduce the mortality. ARRT needs multidimensional approach depending on the patient condition. Which form of RRT, its dosage and more importantly the right timing for its initiation (proactive or rescue therapy). All these issues have been dealt with in a simple manner to drive home the message that therapy has to be individualized.
There is a chapter devoted to continuous renal replacement therapy (CRRT) in paediatric population, which deals with both the clinical and specific technical aspects of this age group. Another chapter addresses the issue of cardiac surgery associated AKI.
This book is of use to nephrologists, intensivists (paediatricians included) as well as internists. Cardiologists and cardiovascular surgeons also have to face the problem of AKI, hence it is a good accompaniment for them. Additionally nursing staff in dialysis and intensive care units will find it useful in understanding the overall concept of AKI from diagnosis to management. Historically, the purpose of measuring biomarkers was to determine the presence or absence of a disease, and to show the efficacy of a specific treatment. In the last two decades this narrow definition has undergone a sea change. With improved health services, the world has seen a decrease in pathogen-borne communicable diseases and an increase in diet and lifestyle related non-communicable diseases. This has given rise to the need for assessing the nutritional status of 'normal' individuals in a community t o identify nutritional deficiencies and excesses. With the technological advances made in the 'omics' sciences the potential for measuring biomarkers have progressed in leaps and bounds. However, the ability to harness this potential to provide useful information is still in its infancy. This book is a timely effort to take stock of the current situation.
Habir Singh Kohli
The book is divided into three distinct sections. The first section, 'Methodologies: Global Epidemiology', charts the journey of biomarker usage from the 20 th century reductionist mind-set to the 21 st century personalized approach. The second section, 'Applications/End Users', includes some specific examples of state-of-the-art biomarker applications in nutrition and health. The final section, 'Future Horizons', focuses on the complex challenges involved in actually utilizing these biomarkers to provide useful information in nutrition-related health care.
The first chapter exploring a systems level approach sets the tone for the rest of the book as an exploration of the reductionist approach that tries to link specific outcomes to specific single exposures; this was appropriate for an era that was controlled by the one-gene-one-polypeptide hypothesis. This is evident in the nutrition workspace -while deficiencies in single nutrients (resulting in diseases such as beriberi, rickets, scurvy) have been successfully dealt with, problems caused due to subclinical under-or over nutrition in populations with diverse genetic and environmental backgrounds are still a black box.
Defining 'good health' is difficult, but the term 'phenotypic flexibility' is introduced as a marker of the ability of an organ (or organism) to adapt to a continuously changing environment caused by diet, infection, stress, etc. Consequently, any loss of flexibility is likely to result in one of many chronic diseases and therefore, such diseases need to be diagnosed and treated using a larger 'systems biology' approach. The processes that adversely influence this flexibility comprise three main components -oxidative, metabolic and inflammatory processes. A single disease can be caused in different individuals due to loss of flexibility in any one of these processes, thus emphasizing the need for a more individualized diagnosis and treatment, aimed at optimizing 'health' in the future. The chapter on bioinformatics and genomic information details how new and advanced computational tools are being developed to extract useful biological insights based on large data sets of genomic and metabolomic information.
There is also the more realistic picture presented, of the use of high-end technologies for quantifying biomarkers. The 'omics' methods are highly sensitive and specific and would be most useful in assessing nutritional biomarkers in large populations. However, the greatest need of these methods are in poorer economies and rural settings where the priority is more on 'cheap and easy-to-apply' methods. A valid point raised is that the large data generated by the former methods are hard to decipher due to the complex modelling involved. Furthermore, it is also a fact that these have not been useful so far in deciding the type of nutritional interventions that would be most beneficial. Given these conditions, it would be of utmost importance and interest to see how a balance between the two can be achieved.
The second section deals with specific and novel nutritional biomarkers for liver disease, iron status, cardiovascular disease, and for long-term outcomes after preterm birth. Liver disease in children or adults is usually accompanied by high morbidity and mortality unless the liver is transplanted. However, the biomarkers used for following disease progression involve invasive and expensive procedures such as liver biopsies, and therefore, identification of novel biomarkers in circulation is a critical requirement. The identification of serum biomarkers such as cytokeratin-18 and the ratio of its cleaved fragments (M30:M65) in differentiating between apoptotic and necrotic cell death is also dealt with. These and other inflammatory markers have been used in conjunction with clinical parameters to predict the severity of fibrosis in liver diseases.
The topical issue of biomarkers for iron status is discussed in a separate chapter. Iron is an essential mineral for oxygen transport and mitochondrial function. However, increasing reports on the possible role of iron induced oxidative stress in a number of disease conditions has given rise to the important question -at what stage does iron switch from being essential to being harmful? The role of the peptide hormone, hepcidin in regulation of dietary iron absorption and distribution within the body is discussed. Anaemia is a global problem especially in developing countries, but supplementation with high levels of iron is not always successful or effective. The regulation of hepcidin expression, and the levels of hepcidin appear to partly determine the likely efficacy of iron therapy.
Two other important issues are dealt with in this section -the increasing incidence of preterm birth and its long-term adverse health consequences. The lack of reliable biomarkers and the recommendation for the use of comprehensive 'omics' approach in large prospective cohort studies have been discussed in one chapter, while novel biomarkers for the diagnosis and treatment of vascular lesions in cardiovascular diseases are detailed in another chapter.
The final section deals with the future of nutritional biomarkers. A useful discussion is presented, on how patient populations need to be stratified into more detailed subsets to predict responses to a particular treatment. For example, novel technologies such as CEER (collaborative enzyme enhanced reactive immunoassay) and HMSA (homogeneous mobility shift assay) have made great strides in dynamic profiling and monitoring in oncology and gastrointestinal diseases.
Approaches to develop a one-stop shop for measuring serum profiles of all essential nutrients including their important metabolites are also described. In effect, this would make the tracking and personalization of the total nutritional status of individuals and the community possible. This book is the 30 th volume of the ongoing series 'Endocrine Development'. It consists of a compilation of chapters on various advanced therapies in paediatric endocrinology and diabetology. This multi author book, written by experts in their fields, gives a comprehensive updated review of recent advances in endocrinology and diabetes.
The book starts off with a section on automated insulin delivery in type 1 diabetes. The authors take us through the history, types, advantages and limitations of closed loop system of insulin delivery. This is followed by a lucid description of current indications and future perspectives of islet cell transplant in paediatric patients and a chapter on treatment of paediatric obesity with reference to glucagon-like peptide-1 (GLP-1) receptor agonists, metformin and orlistat.
Chapter 4 is a well written account of the role of docosahexaenoic acid in G-protein coupled receptor 120 activation in paediatric non-alcoholic fatty liver disease. This is followed by a chapter on noninvasive prenatal diagnosis of congenital adrenal hyperplasia, which brings forth how using cell-free foetal DNA, in mothers carrying 'at risk' foetuses, a diagnosis can be established in as early as six weeks and unnecessary prenatal administration of low dose dexamethasone can be prevented.
Following this is a crisp description of inadequacies of conventional hydrocortisone replacement and the newer options available to replace cortisol in a physiological manner. This includes oral mixed release drug formulations and continuous subcutaneous hydrocortisone infusion to approximate physiological rhythm in adrenal insufficiency and congenital adrenal hyperplasia.
The next chapter deals well with subcutaneous implant of gonadotropin releasing hormone analogue histrelin in management of central precocious puberty. This is followed by a vivid description of medications available for hypogonadotrophic hypogonadism and the recent molecules such as kisspeptin and neurokinin B agonists under evaluation for therapy of delayed puberty. Then there is an update on status of recent formulation of sustained release, long acting recombinant human growth hormone for paediatric use.
The next few chapters deal with potential therapeutic strategies for achondroplasia focusing on C-type natriuretic peptide analogue. This is followed by an exhaustive account of therapeutic neuroendocrine agonist and antagonist analogues of hypothalamic neuropeptides as modulators of hypothalamic-pituitary-gonadal axis. This chapter not only deals with their application in treating numerous conditions like precocious and delayed puberty, prostate cancer, benign prostate hyperplasia, endometriosis, uterine fibroids and in vitro fertilization protocols, but also throws light on kisspeptin and neurokinin B agonists and antagonists which are being developed as newer drugs in this area.
Chapter 12 reviews published findings on the use of aromatase inhibitors in growth with evidence of its role in the aetiology of various diseases. A major role of dietary nutrients might be their influence on the type and function of microbes in the gut, which in turn can affect the development of metabolic diseases. All this is possible due to the advances in sequencing and mass spectroscopy techniques working in conjunction with enhanced biocomputational tools that can handle and interpret large data sets.
Overall, this book is a good introduction into the field of nutritional biomarkers. This is a rapidly growing field and the quest for sensitive, specific, non-invasive biomarkers is throwing up new information on a regular basis. Ultimately, the goal of personalized nutrition seems more and more possible in the future.
